Skip to main content
VANI
NASDAQ Life Sciences

SLIM-1 Data: Semaglutide Implant Matches Wegovy Weight Loss With Zero Treatment-Related AEs

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.17
Mkt Cap
$101.93M
52W Low
$0.923
52W High
$1.661
52W Position info
27% above low
Off High info
30% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

VANI sits 27% above its 52-week low of $0.923.

Summary

Vivani's SLIM-1 Phase 1 readout is the binary event the stock has been waiting on, and it came in clean. None of the 10 NPM-139 implant subjects had treatment-related adverse events versus 5 of 10 in the Wegovy control group, and the implant produced no rapid drug spikes — peak levels at roughly 16 days versus about 2.4 days for weekly Wegovy. Weight loss was essentially a tie: 0.79% for NPM-139 versus 0.82% for Wegovy over the four-week study, with no serious adverse events and uncomplicated insertions and removals. The company will push NPM-139 into a Phase 2 dose-ranging weight maintenance trial anticipated to begin in 2027, and will explore GLP-1-naïve patients given the tolerability profile. This lands the day after the Q3 report showing a $7.3M quarterly loss and alongside the 10-Q's going-concern warning and cash runway ending Q1 2027 — so the data validates the platform but the balance sheet still needs funding before that Phase 2 starts.

At the time of this announcement, VANI was trading at $1.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $101.9M. The 52-week trading range was $0.92 to $1.66. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

VANI - Latest Insights

VANI
Nov 12, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.18
Real-time Price: $1.13 info
Change: -$0.0518 (-4%) info
Market Cap: $101.93M info
VANI
Nov 11, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.13
Real-time Price: $1.13 info
Change: $0 (0%) info
Market Cap: $101.93M info
VANI
Aug 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $1.13 info
Change: -$0.210 (-16%) info
Market Cap: $101.93M info
VANI
Aug 06, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.40
Real-time Price: $1.13 info
Change: -$0.270 (-19%) info
Market Cap: $101.93M info
VANI
Jul 16, 2026, 9:00 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $1.13 info
Change: -$0.280 (-20%) info
Market Cap: $101.93M info